Literature DB >> 10713632

Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-L-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodystrophy), arylsulfatase A (metachromatic leukodystrophy), arylsulfatase B (Maroteaux-Lamy).

R deGasperi1, S S Raghavan, M G Sosa, E H Kolodny, C Carrier, P Rubenstein, C Peters, J Wagner, J Kurtzberg, W Krivit.   

Abstract

Umbilical cord blood (UCB) has received increasing attention as a source of unrelated hematopoietic stem cells for transplantation. Lysosomal diseases have been effectively treated and normal enzymatic activity has occurred subsequent to engraftment using UCB. The use of donor cells with normal amounts of enzyme, rather than those from carriers whose level may be 50% or less, is an obvious goal. The frequency of such heterozygotes varies from 1:10 to 1:140 or lower depending upon the disease at issue. We assayed the levels of lysosomal enzymes in normal UCB in random samples as well as those used for transplantation. We measured the following enzymatic activities: alpha-l-iduronidase (Hurler), galactocerebrosidase (globoid cell leuko- dystrophy) and arylsulfatase A (metachromatic leukodystrophy). For the latter, levels of activity in UCB are comparable to those found in adult blood. In the case of arylsulfatase B (Maroteaux-Lamy) a level lower than adult level was found. An informed choice by the transplanting physician based on the activity of the relevant enzyme in the UCB donor will provide a better opportunity for an improved prognosis for more complete correction of the recipient's primary disease. Bone Marrow Transplantation (2000) 25, 541-544.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713632     DOI: 10.1038/sj.bmt.1702185

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations.

Authors:  S Raghavan; B Zeng; P A Torres; G M Pastores; E H Kolodny; J Kurtzberg; W Krivit
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

Authors:  Vinod K Prasad; Adam Mendizabal; Suhag H Parikh; Paul Szabolcs; Timothy A Driscoll; Kristin Page; Sonali Lakshminarayanan; June Allison; Susan Wood; Deborah Semmel; Maria L Escolar; Paul L Martin; Shelly Carter; Joanne Kurtzberg
Journal:  Blood       Date:  2008-06-27       Impact factor: 22.113

Review 3.  Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases.

Authors:  William Krivit
Journal:  Springer Semin Immunopathol       Date:  2004-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.